Mecanismos moleculares de inflamación durante las agudizaciones de la enfermedad pulmonar obstructiva crónica

Changes were observed in different pulmonary and systemic inflammatory markers during ECOPD, that were not completely resolved during stability. However, current treatment does not allow the modification of HDAC activity, which limits its anti-inflammatory effects.